ProofPilot Revolutionizes Clinical Trials with Series C Funding Boost
New York-based ProofPilot, a frontrunner in the Clinical Experience Platform (CXP) space, has announced the successful closing of its Series C funding round. Sopris Capital led the investment, with participation from Mitsui & Co. (U.S.A.), Inc. This significant investment underscores the growing recognition of ProofPilot’s innovative approach to clinical trials. While advancements in data capture…